Does the media prefer JAN or OHI?

In the previous week, JAN had 196 more articles in the media than Omega Healthcare Investors. MarketBeat recorded 201 mentions for JAN and 5 mentions for Omega Healthcare Investors. JAN's average media sentiment score of 1.77 beat Omega Healthcare Investors' score of 0.91 indicating that JAN is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment JAN 182 Very Positive mention(s) 2 Positive mention(s) 10 Neutral mention(s) 2 Negative mention(s) 3 Very Negative mention(s) Very Positive Omega Healthcare Investors 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Which has higher earnings and valuation, DOC or JAN?

Healthpeak Properties has higher revenue and earnings than JAN. JAN is trading at a lower price-to-earnings ratio than Healthpeak Properties, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Healthpeak Properties $2.82B 5.08 $71.35M $0.35 59.44 JAN $603.99M 13.06 $6.35M -$0.05 N/A

Does the media refer more to DOC or JAN?

In the previous week, JAN had 187 more articles in the media than Healthpeak Properties. MarketBeat recorded 201 mentions for JAN and 14 mentions for Healthpeak Properties. JAN's average media sentiment score of 1.77 beat Healthpeak Properties' score of 0.81 indicating that JAN is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Healthpeak Properties 7 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive JAN 182 Very Positive mention(s) 2 Positive mention(s) 10 Neutral mention(s) 2 Negative mention(s) 3 Very Negative mention(s) Very Positive

Does the media prefer AHR or JAN?

In the previous week, JAN had 185 more articles in the media than American Healthcare REIT. MarketBeat recorded 201 mentions for JAN and 16 mentions for American Healthcare REIT. JAN's average media sentiment score of 1.77 beat American Healthcare REIT's score of 0.78 indicating that JAN is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment American Healthcare REIT 7 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive JAN 182 Very Positive mention(s) 2 Positive mention(s) 10 Neutral mention(s) 2 Negative mention(s) 3 Very Negative mention(s) Very Positive

Which has stronger earnings & valuation, CTRE or JAN?

CareTrust REIT has higher earnings, but lower revenue than JAN. JAN is trading at a lower price-to-earnings ratio than CareTrust REIT, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CareTrust REIT $476.39M 19.25 $320.54M $1.59 24.41 JAN $603.99M 13.06 $6.35M -$0.05 N/A

Does the media prefer CTRE or JAN?

In the previous week, JAN had 190 more articles in the media than CareTrust REIT. MarketBeat recorded 201 mentions for JAN and 11 mentions for CareTrust REIT. JAN's average media sentiment score of 1.77 beat CareTrust REIT's score of 0.58 indicating that JAN is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CareTrust REIT 6 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive JAN 182 Very Positive mention(s) 2 Positive mention(s) 10 Neutral mention(s) 2 Negative mention(s) 3 Very Negative mention(s) Very Positive

Does the media favor JAN or ARE?

In the previous week, JAN had 190 more articles in the media than Alexandria Real Estate Equities. MarketBeat recorded 201 mentions for JAN and 11 mentions for Alexandria Real Estate Equities. JAN's average media sentiment score of 1.77 beat Alexandria Real Estate Equities' score of 0.38 indicating that JAN is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment JAN 182 Very Positive mention(s) 2 Positive mention(s) 10 Neutral mention(s) 2 Negative mention(s) 3 Very Negative mention(s) Very Positive Alexandria Real Estate Equities 3 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Neutral

JAN (JAN) Competitors

$29.98 +0.88 (+3.03%)

Closing price 08/13/2026 03:59 PM Eastern

Extended Trading

$29.95 -0.03 (-0.11%)

As of 08/13/2026 04:19 PM Eastern

Compare

JAN vs. OHI, DOC, AHR, CTRE, and ARE

Should you buy JAN stock or one of its competitors? JAN's main competitors and comparable companies include Omega Healthcare Investors (OHI), Healthpeak Properties (DOC), American Healthcare REIT (AHR), CareTrust REIT (CTRE), and Alexandria Real Estate Equities (ARE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare reits" industry.

How does JAN compare to Omega Healthcare Investors?

JAN (NYSE:JAN) and Omega Healthcare Investors (NYSE:OHI) are both real estate companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, analyst recommendations, earnings, dividends and profitability.

Omega Healthcare Investors has a net margin of 66.96% compared to JAN's net margin of 0.00%. Omega Healthcare Investors' return on equity of 15.76% beat JAN's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
JAN	N/A	N/A	N/A
Omega Healthcare Investors	66.96%	15.76%	8.40%

In the previous week, JAN had 196 more articles in the media than Omega Healthcare Investors. MarketBeat recorded 201 mentions for JAN and 5 mentions for Omega Healthcare Investors. JAN's average media sentiment score of 1.77 beat Omega Healthcare Investors' score of 0.91 indicating that JAN is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
JAN	182 Very Positive mention(s)	2 Positive mention(s)	10 Neutral mention(s)	2 Negative mention(s)	3 Very Negative mention(s)	Very Positive
Omega Healthcare Investors	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

JAN pays an annual dividend of $0.57 per share and has a dividend yield of 1.9%. Omega Healthcare Investors pays an annual dividend of $2.72 per share and has a dividend yield of 5.9%. JAN pays out -1,140.0% of its earnings in the form of a dividend. Omega Healthcare Investors pays out 97.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

JAN presently has a consensus price target of $30.15, indicating a potential upside of 0.57%. Omega Healthcare Investors has a consensus price target of $49.21, indicating a potential upside of 6.85%. Given Omega Healthcare Investors' higher probable upside, analysts plainly believe Omega Healthcare Investors is more favorable than JAN.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
JAN	0 Sell rating(s)	3 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.86
Omega Healthcare Investors	2 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.27

6.3% of JAN shares are held by institutional investors. Comparatively, 65.3% of Omega Healthcare Investors shares are held by institutional investors. 3.0% of JAN shares are held by insiders. Comparatively, 1.7% of Omega Healthcare Investors shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Omega Healthcare Investors has higher revenue and earnings than JAN. JAN is trading at a lower price-to-earnings ratio than Omega Healthcare Investors, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
JAN	$603.99M	13.06	$6.35M	-$0.05	N/A
Omega Healthcare Investors	$1.19B	11.73	$572.03M	$2.80	16.45

Summary

Omega Healthcare Investors beats JAN on 10 of the 18 factors compared between the two stocks.

How does JAN compare to Healthpeak Properties?

Healthpeak Properties (NYSE:DOC) and JAN (NYSE:JAN) are both real estate companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends, risk and media sentiment.

Healthpeak Properties has higher revenue and earnings than JAN. JAN is trading at a lower price-to-earnings ratio than Healthpeak Properties, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Healthpeak Properties	$2.82B	5.08	$71.35M	$0.35	59.44
JAN	$603.99M	13.06	$6.35M	-$0.05	N/A

Healthpeak Properties pays an annual dividend of $1.22 per share and has a dividend yield of 5.9%. JAN pays an annual dividend of $0.57 per share and has a dividend yield of 1.9%. Healthpeak Properties pays out 348.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. JAN pays out -1,140.0% of its earnings in the form of a dividend.

93.6% of Healthpeak Properties shares are held by institutional investors. Comparatively, 6.3% of JAN shares are held by institutional investors. 0.2% of Healthpeak Properties shares are held by insiders. Comparatively, 3.0% of JAN shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Healthpeak Properties has a net margin of 8.24% compared to JAN's net margin of 0.00%. Healthpeak Properties' return on equity of 2.79% beat JAN's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Healthpeak Properties	8.24%	2.79%	1.17%
JAN	N/A	N/A	N/A

In the previous week, JAN had 187 more articles in the media than Healthpeak Properties. MarketBeat recorded 201 mentions for JAN and 14 mentions for Healthpeak Properties. JAN's average media sentiment score of 1.77 beat Healthpeak Properties' score of 0.81 indicating that JAN is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Healthpeak Properties	7 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
JAN	182 Very Positive mention(s)	2 Positive mention(s)	10 Neutral mention(s)	2 Negative mention(s)	3 Very Negative mention(s)	Very Positive

Healthpeak Properties currently has a consensus price target of $21.44, indicating a potential upside of 3.06%. JAN has a consensus price target of $30.15, indicating a potential upside of 0.57%. Given Healthpeak Properties' higher possible upside, research analysts clearly believe Healthpeak Properties is more favorable than JAN.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Healthpeak Properties	0 Sell rating(s)	15 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.21
JAN	0 Sell rating(s)	3 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.86

Summary

Healthpeak Properties beats JAN on 10 of the 18 factors compared between the two stocks.

How does JAN compare to American Healthcare REIT?

American Healthcare REIT (NYSE:AHR) and JAN (NYSE:JAN) are both real estate companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, valuation, earnings, media sentiment, institutional ownership and profitability.

American Healthcare REIT has a net margin of 4.84% compared to JAN's net margin of 0.00%. American Healthcare REIT's return on equity of 3.63% beat JAN's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
American Healthcare REIT	4.84%	3.63%	2.25%
JAN	N/A	N/A	N/A

American Healthcare REIT pays an annual dividend of $1.00 per share and has a dividend yield of 1.9%. JAN pays an annual dividend of $0.57 per share and has a dividend yield of 1.9%. American Healthcare REIT pays out 147.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. JAN pays out -1,140.0% of its earnings in the form of a dividend. JAN is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, JAN had 185 more articles in the media than American Healthcare REIT. MarketBeat recorded 201 mentions for JAN and 16 mentions for American Healthcare REIT. JAN's average media sentiment score of 1.77 beat American Healthcare REIT's score of 0.78 indicating that JAN is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
American Healthcare REIT	7 Very Positive mention(s)	1 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
JAN	182 Very Positive mention(s)	2 Positive mention(s)	10 Neutral mention(s)	2 Negative mention(s)	3 Very Negative mention(s)	Very Positive

16.7% of American Healthcare REIT shares are held by institutional investors. Comparatively, 6.3% of JAN shares are held by institutional investors. 0.8% of American Healthcare REIT shares are held by company insiders. Comparatively, 3.0% of JAN shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

American Healthcare REIT currently has a consensus price target of $59.67, indicating a potential upside of 11.31%. JAN has a consensus price target of $30.15, indicating a potential upside of 0.57%. Given American Healthcare REIT's higher possible upside, equities research analysts plainly believe American Healthcare REIT is more favorable than JAN.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Healthcare REIT	0 Sell rating(s)	2 Hold rating(s)	12 Buy rating(s)	0 Strong Buy rating(s)	2.86
JAN	0 Sell rating(s)	3 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.86

American Healthcare REIT has higher revenue and earnings than JAN. JAN is trading at a lower price-to-earnings ratio than American Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
American Healthcare REIT	$2.26B	4.57	$69.81M	$0.68	78.83
JAN	$603.99M	13.06	$6.35M	-$0.05	N/A

Summary

American Healthcare REIT beats JAN on 10 of the 17 factors compared between the two stocks.

How does JAN compare to CareTrust REIT?

CareTrust REIT (NYSE:CTRE) and JAN (NYSE:JAN) are both mid-cap real estate companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, risk, media sentiment, analyst recommendations and valuation.

CareTrust REIT pays an annual dividend of $1.56 per share and has a dividend yield of 4.0%. JAN pays an annual dividend of $0.57 per share and has a dividend yield of 1.9%. CareTrust REIT pays out 98.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. JAN pays out -1,140.0% of its earnings in the form of a dividend. CareTrust REIT has increased its dividend for 3 consecutive years. CareTrust REIT is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

CareTrust REIT has higher earnings, but lower revenue than JAN. JAN is trading at a lower price-to-earnings ratio than CareTrust REIT, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareTrust REIT	$476.39M	19.25	$320.54M	$1.59	24.41
JAN	$603.99M	13.06	$6.35M	-$0.05	N/A

87.8% of CareTrust REIT shares are held by institutional investors. Comparatively, 6.3% of JAN shares are held by institutional investors. 0.7% of CareTrust REIT shares are held by company insiders. Comparatively, 3.0% of JAN shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

CareTrust REIT has a net margin of 62.19% compared to JAN's net margin of 0.00%. CareTrust REIT's return on equity of 8.52% beat JAN's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareTrust REIT	62.19%	8.52%	6.64%
JAN	N/A	N/A	N/A

CareTrust REIT presently has a consensus target price of $44.91, suggesting a potential upside of 15.70%. JAN has a consensus target price of $30.15, suggesting a potential upside of 0.57%. Given CareTrust REIT's stronger consensus rating and higher possible upside, analysts clearly believe CareTrust REIT is more favorable than JAN.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareTrust REIT	0 Sell rating(s)	2 Hold rating(s)	9 Buy rating(s)	2 Strong Buy rating(s)	3.00
JAN	0 Sell rating(s)	3 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.86

In the previous week, JAN had 190 more articles in the media than CareTrust REIT. MarketBeat recorded 201 mentions for JAN and 11 mentions for CareTrust REIT. JAN's average media sentiment score of 1.77 beat CareTrust REIT's score of 0.58 indicating that JAN is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CareTrust REIT	6 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
JAN	182 Very Positive mention(s)	2 Positive mention(s)	10 Neutral mention(s)	2 Negative mention(s)	3 Very Negative mention(s)	Very Positive

Summary

CareTrust REIT beats JAN on 13 of the 19 factors compared between the two stocks.

How does JAN compare to Alexandria Real Estate Equities?

JAN (NYSE:JAN) and Alexandria Real Estate Equities (NYSE:ARE) are both mid-cap real estate companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.

In the previous week, JAN had 190 more articles in the media than Alexandria Real Estate Equities. MarketBeat recorded 201 mentions for JAN and 11 mentions for Alexandria Real Estate Equities. JAN's average media sentiment score of 1.77 beat Alexandria Real Estate Equities' score of 0.38 indicating that JAN is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
JAN	182 Very Positive mention(s)	2 Positive mention(s)	10 Neutral mention(s)	2 Negative mention(s)	3 Very Negative mention(s)	Very Positive
Alexandria Real Estate Equities	3 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	4 Negative mention(s)	0 Very Negative mention(s)	Neutral

JAN has a net margin of 0.00% compared to Alexandria Real Estate Equities' net margin of -36.08%. JAN's return on equity of 0.00% beat Alexandria Real Estate Equities' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
JAN	N/A	N/A	N/A
Alexandria Real Estate Equities	-36.08%	-5.21%	-2.92%

6.3% of JAN shares are held by institutional investors. Comparatively, 96.5% of Alexandria Real Estate Equities shares are held by institutional investors. 3.0% of JAN shares are held by insiders. Comparatively, 1.4% of Alexandria Real Estate Equities shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

JAN has higher earnings, but lower revenue than Alexandria Real Estate Equities. JAN is trading at a lower price-to-earnings ratio than Alexandria Real Estate Equities, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
JAN	$603.99M	13.06	$6.35M	-$0.05	N/A
Alexandria Real Estate Equities	$3.03B	2.79	-$1.43B	-$6.06	N/A

JAN pays an annual dividend of $0.57 per share and has a dividend yield of 1.9%. Alexandria Real Estate Equities pays an annual dividend of $2.88 per share and has a dividend yield of 5.9%. JAN pays out -1,140.0% of its earnings in the form of a dividend. Alexandria Real Estate Equities pays out -47.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Alexandria Real Estate Equities has increased its dividend for 15 consecutive years. Alexandria Real Estate Equities is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

JAN presently has a consensus target price of $30.15, indicating a potential upside of 0.57%. Alexandria Real Estate Equities has a consensus target price of $52.62, indicating a potential upside of 8.55%. Given Alexandria Real Estate Equities' higher possible upside, analysts plainly believe Alexandria Real Estate Equities is more favorable than JAN.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
JAN	0 Sell rating(s)	3 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.86
Alexandria Real Estate Equities	4 Sell rating(s)	10 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.88

Summary

JAN beats Alexandria Real Estate Equities on 13 of the 19 factors compared between the two stocks.

Get JAN News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding JAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

JAN vs. The Competition

Export

Metric	JAN	Healthcare REITs Industry	Real Estate Sector	NYSE Exchange
Market Cap	$7.66B	$12.24B	$5.61B	$24.30B
Dividend Yield	1.96%	5.78%	6.19%	3.69%
P/E Ratio	-599.66	62.82	30.20	30.16
Price / Sales	13.06	109.96	139.04	21.51
Price / Cash	N/A	24.80	34.51	33.80
Price / Book	2.13	1.89	1.92	6.69
Net Income	$6.35M	-$1.49M	-$63.69M	$1.06B
7 Day Performance	-1.70%	-1.88%	0.21%	0.45%
1 Month Performance	1.59%	-0.22%	-0.08%	3.07%
1 Year Performance	N/A	19.23%	12.90%	18.36%

JAN Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
JAN JAN	2.7492 of 5 stars	$29.98 +3.0%	$30.15 +0.6%	N/A	$7.66B	$603.99M	N/A	N/A	Trending News Analyst Forecast
OHI Omega Healthcare Investors	3.6249 of 5 stars	$48.52 -0.3%	$49.21 +1.4%	+14.0%	$14.75B	$1.19B	17.33	50
DOC Healthpeak Properties	2.3859 of 5 stars	$21.37 +1.3%	$20.97 -1.9%	+21.3%	$14.55B	$2.82B	61.07	200	Analyst Forecast
AHR American Healthcare REIT	2.4818 of 5 stars	$56.81 +3.8%	$58.83 +3.6%	+31.8%	$10.54B	$2.26B	83.54	110	Earnings Report Analyst Forecast
CTRE CareTrust REIT	4.0121 of 5 stars	$41.22 +0.2%	$44.82 +8.7%	+17.4%	$9.72B	$476.39M	25.92	20	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:JAN) was last updated on 8/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

JAN (JAN) Competitors

JAN vs. OHI, DOC, AHR, CTRE, and ARE

How does JAN compare to Omega Healthcare Investors?

Summary

How does JAN compare to Healthpeak Properties?

Summary

How does JAN compare to American Healthcare REIT?

Summary

How does JAN compare to CareTrust REIT?

Summary

How does JAN compare to Alexandria Real Estate Equities?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

JAN vs. The Competition

JAN Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

JAN (JAN) Competitors

JAN vs. OHI, DOC, AHR, CTRE, and ARE

How does JAN compare to Omega Healthcare Investors?

Is JAN or OHI more profitable?

Does the media prefer JAN or OHI?

Is JAN or OHI a better dividend stock?

Do analysts prefer JAN or OHI?

Do insiders & institutionals have more ownership in JAN or OHI?

Which has preferable valuation and earnings, JAN or OHI?

Summary

How does JAN compare to Healthpeak Properties?

Which has higher earnings and valuation, DOC or JAN?

Is DOC or JAN a better dividend stock?

Do institutionals & insiders hold more shares of DOC or JAN?

Is DOC or JAN more profitable?

Does the media refer more to DOC or JAN?

Do analysts prefer DOC or JAN?

Summary

How does JAN compare to American Healthcare REIT?

Is AHR or JAN more profitable?

Is AHR or JAN a better dividend stock?

Does the media prefer AHR or JAN?

Do institutionals and insiders hold more shares of AHR or JAN?

Do analysts rate AHR or JAN?

Which has higher valuation and earnings, AHR or JAN?

Summary

How does JAN compare to CareTrust REIT?

Is CTRE or JAN a better dividend stock?

Which has stronger earnings & valuation, CTRE or JAN?

Do insiders & institutionals believe in CTRE or JAN?

Is CTRE or JAN more profitable?

Do analysts recommend CTRE or JAN?

Does the media prefer CTRE or JAN?

Summary

How does JAN compare to Alexandria Real Estate Equities?

Does the media favor JAN or ARE?

Is JAN or ARE more profitable?

Do institutionals & insiders hold more shares of JAN or ARE?

Which has stronger valuation & earnings, JAN or ARE?

Is JAN or ARE a better dividend stock?

Do analysts prefer JAN or ARE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

JAN vs. The Competition

JAN Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools